Work

Fluoxetine for the Treatment of Childhood Anxiety Disorders: Open-Label, Long-Term Extension to a Controlled Trial

Year: 2005

Type: article

Source: Journal of the American Academy of Child & Adolescent Psychiatry

DOI: 10.1097/01.chi.0000183464.41777.c1

Authors: DUNCAN B. CLARK, BORIS BIRMAHER, DAVID AXELSON, KELLY MONK, CATHERINE KALAS, MARY EHMANN, JEFFREY BRIDGE, D. SCOTT WOOD, BENGT MUTHEN, DAVID BRENT

Institutions: University of California, Los Angeles, University of Pittsburgh Medical Center

Language: English

Topic: Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Subfield: Experimental and Cognitive Psychology

Field: Psychology

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, U.S. Public Health Service, National Institute on Alcohol Abuse and Alcoholism, National Institute of Mental Health

Awards: G2594283007, G3529594443, FLUOXETINE FOR ANXIOUS CHILDREN, CADPRC FOR EARLY ONSET AFFECTIVE AND ANXIETY DISORDERS, G7452387472, Adolescent Psychopathology and Alcohol Use Disorders, G87823837, G97038983

OpenAlex ID: W2157344752

FWCI: 3.455

Cites: 28

Cited by: 60

Related to: 10